U.S. markets close in 4 hours 52 minutes

Corcept Therapeutics Incorporated (CORT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.83+0.13 (+0.95%)
As of 11:08AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 8/13/2020
Current
6/30/20203/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
1.55B1.94B1.36B1.39B1.61B1.28B
Enterprise Value 3
1.15B1.60B1.09B1.16B1.39B1.10B
Trailing P/E
14.3119.3315.4417.0422.4418.28
Forward P/E 1
14.4717.7012.5812.8715.6213.12
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
4.696.134.755.226.555.42
Price/Book (mrq)
3.434.753.674.155.414.43
Enterprise Value/Revenue 3
3.2818.0411.6913.1417.0315.16
Enterprise Value/EBITDA 6
8.0544.6628.4532.4741.3543.53

Trading Information

Stock Price History

Beta (5Y Monthly) 1.07
52-Week Change 35.47%
S&P500 52-Week Change 316.78%
52 Week High 318.52
52 Week Low 39.70
50-Day Moving Average 315.89
200-Day Moving Average 313.87

Share Statistics

Avg Vol (3 month) 31.07M
Avg Vol (10 day) 31.42M
Shares Outstanding 5115.56M
Float 95.81M
% Held by Insiders 19.98%
% Held by Institutions 175.49%
Shares Short (Jul 30, 2020) 422.1M
Short Ratio (Jul 30, 2020) 427.22
Short % of Float (Jul 30, 2020) 425.01%
Short % of Shares Outstanding (Jul 30, 2020) 419.12%
Shares Short (prior month Jun 29, 2020) 422.65M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 32.49%
Operating Margin (ttm)40.14%

Management Effectiveness

Return on Assets (ttm)21.32%
Return on Equity (ttm)30.36%

Income Statement

Revenue (ttm)351.21M
Revenue Per Share (ttm)3.07
Quarterly Revenue Growth (yoy)22.60%
Gross Profit (ttm)300.98M
EBITDA 141.79M
Net Income Avi to Common (ttm)114.11M
Diluted EPS (ttm)0.94
Quarterly Earnings Growth (yoy)40.30%

Balance Sheet

Total Cash (mrq)405.36M
Total Cash Per Share (mrq)3.51
Total Debt (mrq)3.5M
Total Debt/Equity (mrq)0.77
Current Ratio (mrq)10.38
Book Value Per Share (mrq)3.93

Cash Flow Statement

Operating Cash Flow (ttm)173.34M
Levered Free Cash Flow (ttm)130.28M